Anna Darnell

TL;DR: The data show an unexpected high rate and pattern of tumor recurrence coinciding with HCV clearance and, although based in a very small cohort of patients, should be taken as a note of caution and prime a large scale assessment that exceeds the individual investigators capacity.

TL;DR: This review summarizes the current knowledge about imaging techniques for the early diagnosis and staging of HCC, and it discusses the most relevant open questions.

TL;DR: Tumor progression is a surrogate of survival but its impact varies according to progression pattern, and this is key in prognostic prediction and second‐line trial design and analysis.

TL;DR: Development of dermatologic adverse events within 60 days of sorafenib initiation is associated with better survival, and should not be taken as a negative event and discourage treatment maintenance.

TL;DR: The main outcomes were the incidence of complications of cirrhosis and mortality according to the presence of SPSS, and quality of life and transplantation-free survival were lower in patients with S PSS vs without.